中國平安AH股齊反彈 昨日獲外資逆勢狂買23.25億元
格隆匯2月4日丨新冠肺炎疫情仍在繼續,經過昨天的大跌後,今日A股市場三大指數紛紛反彈,滬指目前漲0.6%,創業板指反彈幅度超3%。 入選格隆匯2020年十大核心資產名單的中國平安在經過昨日的回調後,今日AH股均出現上漲走勢,A股漲2%,H股漲1.6%,有數據顯示,昨日外資逆勢狂買中國平安A股23.25億元,為淨買入金額最多的個股。 有業內分析人士指出:“疫情短期對保險業的影響主要體現在負債端的一季度新單銷售和代理人下滑等方面。認為A股保險股在期初調整後將迎來價值投資者配置的良機,二季度或將看到業務景氣度提升的基本面改善。還有觀點認為,疫情催化的保險保障意識或將加速後期改革進程,幫助NBV增長提速,具備長期價值增長的中國平安目前的調整無疑是介入的良機。”
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.